Effect of exogenous DNA injection on leukopoietic repair and antitumor action of cyclophosphamide

Voprosy Onkologii

Volumn 52, Issue 3, 2006, Pages 336-340

  Nikolin, V P ^a   Popova, N A ^a   Sebeleva, T Ye ^a   Strounkin, D N ^b   Rogachev, V A ^a   Semenov, D V ^c   Bogachev, S S ^a   Yakubov, L A ^d   Shurdov, M A ^e  

^a INSTITUTE OF CYTOLOGY AND GENETICS   (Russian Federation)

^b Oncological Dispensary   (Russian Federation)

^c INSTITUTE OF CHEMICAL BIOLOGY AND FUNDAMENTAL MEDICINE   (Russian Federation)

^d Panagenic International Inc   (United States)

^e TD CHEAS Co   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DNA;

ANIMAL; ARTICLE; CBA MOUSE; DRUG EFFECT; LEUKOPOIESIS; MALE; MOUSE;

ANIMALS; ANTINEOPLASTIC AGENTS; CYCLOPHOSPHAMIDE; DNA; LEUKOPOIESIS; MALE; MICE; MICE, INBRED CBA;

EID: 33746340262     PISSN: 05073758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Langston L.D., Simington L.S. Gene targeting in yeast is initiated by two independent strand invasions // Proc. Natl. Acad. Sci. (USA).-2004.-Vol. 104.-P. 15392-15397.
2. Li J., Read L.R., Baker M.D. The mechanism of mammalian gene replacement is based on the formation of long regions of heteroduplex DNA associated with two crossing-over events // Mol. Cel. Biol.-2001.-Vol. 21.-P. 501-510
3. Peterson C.L., Cote J. Cellular machineries for chromosomal DNA repair // Gen. Dev.-2004.-Vol.18.-P. 602-616.
4. Pfeifer P. The mutagenic potential of DNA double-strand break repair // Toxicol. Lett.-1998.-Vol. 96.-P. 119-129.
5. Sung P., Krejci L., van Komen S., Sehorn M.G. Rad51 recombinase and recombination mediators // J. Biol. Chem.-2003.-Vol. 278.-P. 42729-42732.
6. Yakubov L.A., Popova N.A., Nikolin V.P. et al. Extracellular genomic DNA protects mice against radiation and chemical mutagens // Genom Bio.-2003.-Vol. 5.-P. 3.
7. Yu L.J., Drewes P., Gustafsson K., Brain E.G.C. et al. In vivo modulation of alternative pathways of P450-catalyzed cyclophosphamide metabolism: impact on pharmacokinetics and antitumor activity // J. Pharmacol. Exp. Ther.-1999.-Vol. 288 (3).-P 928-937.